Home/Filings/4/0001136261-19-000011
4//SEC Filing

Mehra Raj 4

Accession 0001136261-19-000011

CIK 0001017491other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 4:31 PM ET

Size

5.5 KB

Accession

0001136261-19-000011

Insider Transaction Report

Form 4
Period: 2019-01-24
Mehra Raj
DirectorSee Remarks10% Owner
Transactions
  • Award

    Common Stock

    2019-01-24+3,081,5463,081,546 total
Footnotes (1)
  • [F1]Shares of common stock of the corporation formerly known as Seelos Therapeutics, Inc. ("Seelos") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of July 30, 2018, by and among the Issuer, Arch Merger Sub, Inc. and Seelos, as amended (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Seelos common stock was exchanged for 0.7704 shares of the Issuer's common stock. Immediately following the merger, the Issuer changed its name to Seelos Therapeutics, Inc. All share numbers reflect the one-for-thirty reverse stock split effected by the Issuer immediately prior to the completion of the merger.

Issuer

SEELOS THERAPEUTICS, INC.

CIK 0001017491

Entity typeother

Related Parties

1
  • filerCIK 0001757892

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:31 PM ET
Size
5.5 KB